Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

A comparison of osteoclast-rich and osteoclast-poor osteopetrosis in adult mice sheds light on the role of the osteoclast in coupling bone resorption and bone formation.

Thudium CS, Moscatelli I, Flores C, Thomsen JS, Brüel A, Gudmann NS, Hauge EM, Karsdal MA, Richter J, Henriksen K.

Calcif Tissue Int. 2014 Jul;95(1):83-93. doi: 10.1007/s00223-014-9865-4. Epub 2014 May 18.

PMID:
24838599
2.

Are nonresorbing osteoclasts sources of bone anabolic activity?

Karsdal MA, Martin TJ, Bollerslev J, Christiansen C, Henriksen K.

J Bone Miner Res. 2007 Apr;22(4):487-94. Review.

3.

ClC-7 expression levels critically regulate bone turnover, but not gastric acid secretion.

Supanchart C, Wartosch L, Schlack C, Kühnisch J, Felsenberg D, Fuhrmann JC, de Vernejoul MC, Jentsch TJ, Kornak U.

Bone. 2014 Jan;58:92-102. doi: 10.1016/j.bone.2013.09.022. Epub 2013 Oct 5.

PMID:
24103576
4.

Dissociation of bone resorption and bone formation in adult mice with a non-functional V-ATPase in osteoclasts leads to increased bone strength.

Henriksen K, Flores C, Thomsen JS, Brüel AM, Thudium CS, Neutzsky-Wulff AV, Langenbach GE, Sims N, Askmyr M, Martin TJ, Everts V, Karsdal MA, Richter J.

PLoS One. 2011;6(11):e27482. doi: 10.1371/journal.pone.0027482. Epub 2011 Nov 7.

5.

Targeted disruption of leucine-rich repeat kinase 1 but not leucine-rich repeat kinase 2 in mice causes severe osteopetrosis.

Xing W, Liu J, Cheng S, Vogel P, Mohan S, Brommage R.

J Bone Miner Res. 2013 Sep;28(9):1962-74. doi: 10.1002/jbmr.1935.

6.

Transgenic mice with OIP-1/hSca overexpression targeted to the osteoclast lineage develop an osteopetrosis bone phenotype.

Shanmugarajan S, Irie K, Musselwhite C, Key LL Jr, Ries WL, Reddy SV.

J Pathol. 2007 Dec;213(4):420-8.

7.

Advances in osteoclast biology resulting from the study of osteopetrotic mutations.

Segovia-Silvestre T, Neutzsky-Wulff AV, Sorensen MG, Christiansen C, Bollerslev J, Karsdal MA, Henriksen K.

Hum Genet. 2009 Jan;124(6):561-77. doi: 10.1007/s00439-008-0583-8. Epub 2008 Nov 6. Review.

PMID:
18987890
9.

Committed osteoclast precursors colonize the bone and improve the phenotype of a mouse model of autosomal recessive osteopetrosis.

Cappariello A, Berardi AC, Peruzzi B, Del Fattore A, Ugazio A, Bottazzo GF, Teti A.

J Bone Miner Res. 2010 Jan;25(1):106-13. doi: 10.1359/jbmr.090715.

10.

Limited rescue of osteoclast-poor osteopetrosis after successful engraftment by cord blood from an unrelated donor.

Nicholls BM, Bredius RG, Hamdy NA, Gerritsen EJ, Lankester AC, Hogendoorn PC, Nesbitt SA, Horton MA, Flanagan AM.

J Bone Miner Res. 2005 Dec;20(12):2264-70. Epub 2005 Aug 8.

11.

The mouse osteopetrotic grey-lethal mutation induces a defect in osteoclast maturation/function.

Rajapurohitam V, Chalhoub N, Benachenhou N, Neff L, Baron R, Vacher J.

Bone. 2001 May;28(5):513-23.

PMID:
11344051
12.

Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation.

Lotinun S, Kiviranta R, Matsubara T, Alzate JA, Neff L, Lüth A, Koskivirta I, Kleuser B, Vacher J, Vuorio E, Horne WC, Baron R.

J Clin Invest. 2013 Feb;123(2):666-81. doi: 10.1172/JCI64840. Epub 2013 Jan 16.

13.

Osteoclasts are not crucial for hematopoietic stem cell maintenance in adult mice.

Flores C, Moscatelli I, Thudium CS, Gudmann NS, Thomsen JS, Brüel A, Karsdal MA, Henriksen K, Richter J.

Haematologica. 2013 Dec;98(12):1848-55. doi: 10.3324/haematol.2013.089466. Epub 2013 Oct 4.

14.

Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period.

Boyce RW, Varela A, Chouinard L, Bussiere JL, Chellman GJ, Ominsky MS, Pyrah IT.

Bone. 2014 Jul;64:314-25. doi: 10.1016/j.bone.2014.04.002. Epub 2014 Apr 13.

PMID:
24727159
15.
16.

Establishment and characterization of new osteoclast progenitor cell lines derived from osteopetrotic and wild type mice.

Blin-Wakkach C, Breuil V, Quincey D, Bagnis C, Carle GF.

Bone. 2006 Jul;39(1):53-60. Epub 2006 Feb 28.

PMID:
16503212
17.

Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption.

Niida S, Kaku M, Amano H, Yoshida H, Kataoka H, Nishikawa S, Tanne K, Maeda N, Nishikawa S, Kodama H.

J Exp Med. 1999 Jul 19;190(2):293-8.

18.

Lessons from osteopetrotic mutations in animals: impact on our current understanding of osteoclast biology.

Van Wesenbeeck L, Van Hul W.

Crit Rev Eukaryot Gene Expr. 2005;15(2):133-62. Review.

PMID:
16022633
19.

Pin1 regulates osteoclast fusion through suppression of the master regulator of cell fusion DC-STAMP.

Islam R, Bae HS, Yoon WJ, Woo KM, Baek JH, Kim HH, Uchida T, Ryoo HM.

J Cell Physiol. 2014 Dec;229(12):2166-74. doi: 10.1002/jcp.24679.

PMID:
24891219
20.

Reduced osteoblastic population and defective mineralization in osteopetrotic (op/op) mice.

Sakagami N, Amizuka N, Li M, Takeuchi K, Hoshino M, Nakamura M, Nozawa-Inoue K, Udagawa N, Maeda T.

Micron. 2005;36(7-8):688-95. Epub 2005 Sep 7.

PMID:
16182547
Items per page

Supplemental Content

Write to the Help Desk